Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

341
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
341
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning models for predicting opaque bubble layer morphology of keratorefractive lenticule extraction before laser scanning.

Advances in ophthalmology practice and research·2026
Same author

CeO<sub>2</sub>@CA@PEI@dextran improves drug sensitivity in chronic myelogenous Leukemia through scavenging free radical efficiently.

Journal of colloid and interface science·2026
Same author

A Conversation Aid for Climate Conscious Inhaler Prescribing.

Chest·2026
Same author

Regulating the Adsorbed Hydrogen Coverage for a Good Trade-Off between Hydrogen Evolution Activity and Electrochemiluminescence Performance.

Analytical chemistry·2026
Same author

Combined exposure to microplastics and PFASs on earthworms: size and concentration effects.

Environmental geochemistry and health·2026
Same author

Inclusive climate perception and voice behavior among new generation employees in China: the role of workplace friendship and relational attribution.

Frontiers in psychology·2026
Same journal

A qualitative study of the impact of the COVID-19 pandemic on healthcare access and service delivery for people living with chronic obstructive pulmonary disease and asthma.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Preventive effect of heat-killed Lactiplantibacillus plantarum FM8 in an ovalbumin-induced food allergy murine model.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Mepolizumab reduces healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps: a linked EMR and claims-based pre-post study.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Triggers, clinical spectra and outcomes of pediatric anaphylaxis in a tertiary center: impact of comorbidities and cofactors on severity.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Declining venom immunotherapy: patient characteristics and clinical outcomes.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Longitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
See all related articles

Related Experiment Video

Updated: May 28, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K

Asthma.

Andrew O'Keefe1, Lori Connors2, Ling Ling3

  • 1Memorial University, St. John's, NF, Canada. okeefe@nlallergy.ca.

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|February 10, 2025
PubMed
Summary
This summary is machine-generated.

Many Canadians have poorly controlled asthma, but effective therapies like inhaled corticosteroids and biologics can help. Proper diagnosis, patient education, and managing comorbidities are crucial for optimal asthma control in all ages.

More Related Videos

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.1K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

5.9K

Related Experiment Videos

Last Updated: May 28, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.8K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.1K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

5.9K

Area of Science:

  • Respiratory Medicine
  • Allergy and Immunology

Background:

  • Asthma is a prevalent respiratory condition in Canada, with a significant portion of patients experiencing suboptimal disease control.
  • Current therapeutic options include inhaled corticosteroids (ICS), ICS/long-acting beta2-agonists (LABA), triple therapy (ICS/LABA/long-acting muscarinic receptor antagonist), and biologics.

Purpose of the Study:

  • To review current literature and guidelines for the diagnosis and management of asthma in adults and children.
  • To highlight advancements in severe asthma treatment, particularly the role of biologic therapies.
  • To emphasize comprehensive asthma management strategies beyond pharmacotherapy.

Main Methods:

  • Review of current scientific literature.
  • Analysis of established clinical guidelines for asthma diagnosis and management.
  • Focus on evidence-based therapeutic approaches and essential management components.

Main Results:

  • Appropriate pharmacotherapy, including ICS, ICS/LABA, triple therapy, and biologics, can achieve asthma control in most patients.
  • Biologic therapies have significantly advanced the medical management of severe asthma.
  • Allergen-specific immunotherapy offers potential disease modification for select asthma patients.
  • Comprehensive management involves regular monitoring, patient education, action plans, addressing adherence barriers, managing comorbidities, and technique review.

Conclusions:

  • Effective asthma management requires a multi-faceted approach, integrating appropriate pharmacotherapy with patient-centered strategies.
  • The landscape of severe asthma treatment has been transformed by biologic therapies.
  • Physician expertise is essential for specific treatments like allergen-specific immunotherapy.